Complicated grief
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.complicated grief as the most important clinical problem 2.more than 26 score of Inventory of Complicated Grief 3.13 months and over after the death of loved one 4.stable antidepressants, antipsychotics, and mood stabilizers medication for a minimum of 3 months, with at least 6 weeks at the same dose. 5.those who can give a written informed consent 6.those who can visit to hospital more than one time per two weeks 7.those who are under treatment at psychiatric or psychosomatic medicine department, and obtain approval from own doctor permission to participate in this intervention
Exclusion criteria
Exclusion criteria: 1.comorbidity of schizophrenia or the other psychotic disorders 2.physical conditions that may interfere this intervention 3.presence of psychiatric symptoms below;manic episode of bipolar disorders, alcohol/drug dependence or abuse, severe depression, PTSD, self-injury, and suicidal attempt. 4.history of alcohol/drug dependence or abuse in past 6 months 5.history of suicidal attempt or severe self-injury in past 6 months 6.concurrent psychotherapy without supportive counseling 7.those who have difficulty for intervention such as cognitive impairment, impaired consciousness, and mental retardation 8.concurrent other clinical trails 9.those who have difficulty for understanding of this intervention, and communicating with clinician in Japanese 10.others whom the principal investigator decides to exclude
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of severity of complicated grief measured by ICG from the pre J-CGT to the 1-2 week after the end of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of prevalence of complicated grief (ICG, CGQ), severity of grief related avoidance symptoms(GRAQ),typical belief related grief(TBQ), depression(BDI-2), anxiety(STAI),traumatic stress symptoms(IES-R),and posttraumatic cognitions(PTCI), QOL (EQ-5D-5L), satisfaction with life (SWLS), social support (SSQ) and the improvement of clinical global impression (CGI-I) from the pre J-CGT to the post J-CGT (1-2 weeks, 3 months and 6 months after the end of treatment) | — |
Countries
Japan
Contacts
Musashino University Faculty of Human sciences